| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1010593159 |
| P356 | DOI | 10.1186/GM247 |
| P932 | PMC publication ID | 3219072 |
| P698 | PubMed publication ID | 21631906 |
| P5875 | ResearchGate publication ID | 51183216 |
| P2093 | author name string | James Hicks | |
| Nicholas Navin | |||
| P2860 | cites work | Cancer as an evolutionary and ecological process | Q22122026 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Isolation of rare circulating tumour cells in cancer patients by microchip technology | Q24597164 | ||
| Distant metastasis occurs late during the genetic evolution of pancreatic cancer | Q24624284 | ||
| Complex landscapes of somatic rearrangement in human breast cancer genomes | Q24631412 | ||
| mRNA-Seq whole-transcriptome analysis of a single cell | Q28240611 | ||
| I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy | Q28244849 | ||
| Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis | Q28280822 | ||
| Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases | Q28289395 | ||
| Molecular definition of breast tumor heterogeneity | Q28292256 | ||
| Real-time DNA sequencing from single polymerase molecules | Q28301519 | ||
| Genome remodelling in a basal-like breast cancer metastasis and xenograft | Q28395637 | ||
| Tumour evolution inferred by single-cell sequencing | Q28646966 | ||
| Inferring tumor progression from genomic heterogeneity | Q28749457 | ||
| Comprehensive human genome amplification using multiple displacement amplification | Q29618737 | ||
| Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution | Q29619477 | ||
| Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization | Q30673310 | ||
| Use of whole genome amplification and comparative genomic hybridisation to detect chromosomal copy number alterations in cell line material and tumour tissue. | Q31082813 | ||
| High resolution array-CGH analysis of single cells | Q33267061 | ||
| Mechanism of chimera formation during the Multiple Displacement Amplification reaction | Q33281958 | ||
| Whole genome amplification and its impact on CGH array profiles. | Q33360956 | ||
| Molecular analysis of multifocal prostate cancer by comparative genomic hybridization | Q33368128 | ||
| Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry | Q33418010 | ||
| Personalized copy number and segmental duplication maps using next-generation sequencing. | Q33498358 | ||
| Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype | Q33604942 | ||
| CNAseg--a novel framework for identification of copy number changes in cancer from second-generation sequencing data. | Q33725108 | ||
| Detection and removal of biases in the analysis of next-generation sequencing reads | Q33815482 | ||
| Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma. | Q34104724 | ||
| Cytogenetic manifestations of multiple myeloma heterogeneity | Q34360608 | ||
| Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer | Q34367966 | ||
| Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH. | Q34373539 | ||
| Genetic clonal diversity predicts progression to esophageal adenocarcinoma | Q34505745 | ||
| Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer. | Q34543718 | ||
| Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases | Q34556958 | ||
| Tracing the derivation of embryonic stem cells from the inner cell mass by single-cell RNA-Seq analysis | Q34619418 | ||
| Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells | Q35129565 | ||
| Novel patterns of genome rearrangement and their association with survival in breast cancer | Q35173695 | ||
| Single-cell PCR analysis of T helper cells in human lymph node germinal centers | Q35809870 | ||
| Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer. | Q36081862 | ||
| High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer | Q36465618 | ||
| High-resolution array comparative genomic hybridization of single micrometastatic tumor cells. | Q36633194 | ||
| Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues | Q36930838 | ||
| High-resolution mapping of copy-number alterations with massively parallel sequencing | Q37072451 | ||
| Whole genome amplification from a single cell: implications for genetic analysis | Q37081188 | ||
| DNA Sudoku--harnessing high-throughput sequencing for multiplexed specimen analysis | Q37247014 | ||
| Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays | Q37318486 | ||
| New technologies for the detection of circulating tumour cells | Q37736981 | ||
| How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine | Q37793837 | ||
| Breast cancer assessment tools and optimizing adjuvant therapy. | Q37803121 | ||
| ERCC5 is a novel biomarker of ovarian cancer prognosis | Q38289922 | ||
| Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity | Q38308859 | ||
| Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens | Q38416233 | ||
| Homogeneity and heterogeneity in pancreas cancer: presence of predominant and minor morphological types and implications | Q39686612 | ||
| Tumor heterogeneity in lung cancer based on light microscopic features. A retrospective study of a consecutive series of 200 patients, treated surgically | Q41452679 | ||
| Whole genome amplification for array comparative genomic hybridization using DNA extracted from formalin-fixed, paraffin-embedded histological sections | Q41769497 | ||
| Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspects | Q42089367 | ||
| Genetic heterogeneity and clonal evolution in neuroblastoma. | Q42137220 | ||
| Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution | Q42524058 | ||
| Sensitive and accurate detection of copy number variants using read depth of coverage | Q42566509 | ||
| Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer | Q43256496 | ||
| Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience | Q43703303 | ||
| Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancer | Q44367943 | ||
| Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy | Q46137363 | ||
| Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer | Q46755338 | ||
| Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria. | Q48001325 | ||
| Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisation. | Q51773510 | ||
| PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer. | Q51789440 | ||
| Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones. | Q52050424 | ||
| Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder. | Q53290873 | ||
| Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. | Q53479490 | ||
| Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH. | Q54017054 | ||
| Bar-coded, multiplexed sequencing of targeted DNA regions using the Illumina Genome Analyzer. | Q54394341 | ||
| Cytogenetic investigation of testicular carcinoma in situ and early seminoma by high-resolution comparative genomic hybridization analysis of subpopulations flow sorted according to DNA content. | Q54724729 | ||
| Intratumoral genetic heterogeneity in pilocytic astrocytomas revealed by CGH-analysis of microdissected tumor cells and FISH on tumor tissue sections. | Q55470679 | ||
| Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma. | Q55480905 | ||
| Clonal heterogeneity in breast cancer: Karyotypic comparisons of multiple intra—and extra—tumorous samples from 3 patients | Q62583461 | ||
| Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer | Q71079815 | ||
| Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups | Q71688238 | ||
| Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer | Q72733504 | ||
| Intratumoral nuclear morphologic heterogeneity in prostate cancer | Q73249807 | ||
| Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group | Q73465824 | ||
| Molecular analysis of the immunoglobulin VH gene rearrangement in a primary cutaneous immunoblastic B-cell lymphoma by micromanipulation and single-cell PCR | Q73775331 | ||
| Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer | Q74576633 | ||
| Flow cytometry--principles and feasibility in transfusion medicine. Enumeration of epithelial derived tumor cells in peripheral blood | Q77092310 | ||
| The genetics of cancer--a 3D model | Q77895897 | ||
| Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA) | Q79611680 | ||
| Intratumoral heterogeneity of HER2/neu in breast cancer--a rare event | Q79825280 | ||
| Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer | Q81199589 | ||
| Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes | Q81313462 | ||
| Circulating melanoma cells and survival in metastatic melanoma | Q83130894 | ||
| Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines | Q83722585 | ||
| HE4: a new potential early biomarker for the recurrence of ovarian cancer | Q83970096 | ||
| Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients | Q83978338 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 31 | |
| P577 | publication date | 2011-05-31 | |
| P1433 | published in | Genome Medicine | Q15816848 |
| P1476 | title | Future medical applications of single-cell sequencing in cancer | |
| P478 | volume | 3 |
| Q34423694 | A new toolbox for assessing single cells |
| Q34794604 | A robust method to analyze copy number alterations of less than 100 kb in single cells using oligonucleotide array CGH. |
| Q27004390 | Advances and applications of single-cell sequencing technologies |
| Q30762666 | An assessment of computational methods for estimating purity and clonality using genomic data derived from heterogeneous tumor tissue samples |
| Q37418714 | Anti-invasive and anti-adhesive activities of a recombinant disintegrin, r-viridistatin 2, derived from the Prairie rattlesnake (Crotalus viridis viridis). |
| Q35135586 | Application of Next Generation Sequencing for personalized medicine for sudden cardiac death |
| Q38254752 | Beyond genome sequencing: lineage tracking with barcodes to study the dynamics of evolution, infection, and cancer. |
| Q43241304 | Broad applications of single-cell nucleic acid analysis in biomedical research. |
| Q34537690 | Cancer genomic research at the crossroads: realizing the changing genetic landscape as intratumoral spatial and temporal heterogeneity becomes a confounding factor |
| Q58132668 | Centrosome aberrations and chromosome instability contribute to tumorigenesis and intra-tumor heterogeneity |
| Q38124901 | Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis |
| Q39157332 | Comparable cytological features between cells processed as either wet mount or conventional cytospins |
| Q43045779 | DNA polymerases in biotechnology |
| Q38068927 | Deciphering the single-cell omic: innovative application for translational medicine. |
| Q53178108 | Detection of Activating Estrogen Receptor Gene (ESR1) Mutations in Single Circulating Tumor Cells. |
| Q48774676 | Deterministic trapping, encapsulation and retrieval of single-cells |
| Q35914897 | Emerging insights into the molecular and cellular basis of glioblastoma |
| Q90051151 | Environmental Carcinogenesis at the Single Cell Level |
| Q28678232 | Evolution of the cancer genome |
| Q53063636 | Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer. |
| Q38778349 | Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing |
| Q36534930 | Frontiers in Suicide Gene Therapy of Cancer |
| Q34395363 | Full-length RNA-seq from single cells using Smart-seq2. |
| Q39012815 | Genome evolution in ductal carcinoma in situ: invasion of the clones |
| Q36740913 | Genome-wide copy number profiling of single cells in S-phase reveals DNA-replication domains |
| Q90644611 | Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma |
| Q28394818 | Getting personalized cancer genome analysis into the clinic: the challenges in bioinformatics |
| Q92934298 | Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset |
| Q38925555 | Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients |
| Q89966162 | High-Throughput Transcriptome Profiling in Drug and Biomarker Discovery |
| Q34335350 | High-purity prostate circulating tumor cell isolation by a polymer nanofiber-embedded microchip for whole exome sequencing. |
| Q30364660 | Highly multiplexed targeted DNA sequencing from single nuclei |
| Q38564005 | Inferring the Origin of Metastases from Cancer Phylogenies |
| Q27015460 | Investigating intratumour heterogeneity by single-cell sequencing |
| Q85908360 | Large (>3.8 cm) clear cell renal cell carcinomas are morphologically and immunohistochemically heterogeneous |
| Q37358959 | Long range personalized cancer treatment strategies incorporating evolutionary dynamics |
| Q27002964 | Making the genomic leap in HCT: application of second-generation sequencing to clinical advances in hematopoietic cell transplantation |
| Q51481422 | Microfluidic device for DNA amplification of single cancer cells isolated from whole blood by self-seeding microwells. |
| Q27340255 | Microfluidic enrichment for the single cell analysis of circulating tumor cells |
| Q96761949 | Molecular identification of Cryptococcus gattii from cerebrospinal fluid using single-cell sequencing: a case study |
| Q41225190 | Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer |
| Q38979961 | Next-generation molecular diagnosis: single-cell sequencing from bench to bedside |
| Q37989166 | Next-generation sequencing: ready for the clinics? |
| Q35114080 | Personalized medicine for gliomas |
| Q92940989 | Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma |
| Q30604285 | Precise pooling and dispensing of microfluidic droplets towards micro- to macro-world interfacing |
| Q35030496 | Precision platform for convex lens-induced confinement microscopy |
| Q59701596 | Primary immunodeficiency diseases in a tuberculosis endemic region: challenges and opportunities |
| Q64249042 | RNA Regulatory Networks as a Control of Stochasticity in Biological Systems |
| Q38159963 | Rapid translation of circulating tumor cell biomarkers into clinical practice: technology development, clinical needs and regulatory requirements |
| Q41430797 | Recent advances in molecular technologies and their application in pathogen detection in foods with particular reference to yersinia |
| Q36723382 | Resolving rates of mutation in the brain using single-neuron genomics |
| Q36161007 | Routing of Biomolecules and Transgenes' Vectors in Nuclei of Oocytes |
| Q51065126 | Scaling advantages and constraints in miniaturized capture assays for single cell protein analysis. |
| Q41713673 | SiFit: inferring tumor trees from single-cell sequencing data under finite-sites models |
| Q34239412 | Single cell genome sequencing |
| Q21563353 | Single cell genomics: advances and future perspectives |
| Q50062475 | Single cell on-chip whole genome amplification via micropillar arrays for reduced amplification bias. |
| Q37653489 | Single cell sequencing: a distinct new field |
| Q55311804 | Single cell transcriptome analysis of MCF-7 reveals consistently and inconsistently expressed gene groups each associated with distinct cellular localization and functions. |
| Q38631119 | Single circulating tumor cell sequencing as an advanced tool in cancer management |
| Q47557398 | Single-Cell Genomic Analysis in Plants. |
| Q26744582 | Single-Cell Sequencing Technology in Oncology: Applications for Clinical Therapies and Research |
| Q38851185 | Single-cell analysis: Advances and future perspectives |
| Q30453107 | Single-cell paired-end genome sequencing reveals structural variation per cell cycle |
| Q52901157 | Single-cell sequencing in cancer research. |
| Q27336129 | Single-cell sequencing reveals karyotype heterogeneity in murine and human malignancies |
| Q41883845 | Single-cell transcriptome in the identification of disease biomarkers: opportunities and challenges |
| Q34743417 | Single-cell, genome-wide sequencing identifies clonal somatic copy-number variation in the human brain |
| Q36503165 | TRA-1-60(+), SSEA-4(+), Oct4A(+), Nanog(+) Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Ovaries |
| Q37244501 | Technological advances in precision medicine and drug development |
| Q36799509 | The genomically mosaic brain: aneuploidy and more in neural diversity and disease |
| Q36849660 | The potential for liquid biopsies in the precision medical treatment of breast cancer |
| Q37900640 | The role of inflammation in the pathogenesis of lung cancer |
| Q37197845 | TrAp: a tree approach for fingerprinting subclonal tumor composition |
| Q64102949 | Translating insights into tumor evolution to clinical practice: promises and challenges |
| Q26744341 | Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance |
| Q27014117 | Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives |
| Q28066914 | Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis |
| Q87370568 | Whole genome and transcriptome amplification: practicable tools for sustainable tissue biobanking? |
Search more.